首页> 外国专利> METHOD OF TREATMENT THROUGH optic atrophy autologous stem cell transplantation

METHOD OF TREATMENT THROUGH optic atrophy autologous stem cell transplantation

机译:视神经萎缩自体干细胞移植的治疗方法

摘要

FIELD: medicine.;SUBSTANCE: method includes delivery of biological material into area of optic nerve by injection parabulbarly, as well as by means of two microdrainages through the incision of sclera into sub-Tenon's and suprachoroidal spaces of eye. As biological material used is autologic cell material in form of suspension of bone marrow mononuclears, which contains patient's stem cells on carrier solution in concentration from 100000 to 1000000 cells per ml of suspension. Introduction is performed in portions every 1-2 hours up to 10 times per day for each separate way of introduction. Parabulbarly 1 ml per injection is introduced. Through microdrainages in sub-Tenon's space introduced are 1-4 ml per injection, into suprachoroidal space - 0.1-0.3 ml per injection.;EFFECT: reduction of blindness and visual impairedness with restoration of structure and functioning of optic nerve due to induction of organotypic tissue regeneration, including vascular net of optic nerve, its disc and peripapillar choroidea.;2 ex
机译:领域:药物:方法包括:通过球囊下注射,以及通过巩膜切口的两个微引流,将生物材料输送到视神经下区域和眼的腱鞘下和脉络膜上腔。作为生物材料,使用的是骨髓单核细胞悬浮液形式的自体细胞材料,其中载有患者干细胞在载体溶液中的浓度为每毫升悬浮液100000至1000000个细胞。每种单独的导入方式,每1-2小时分批进行一次,每天最多进行10次。每次注射约1毫升。通过在Tenon子空间的微排泄,每次注入1-4毫升,进入脉络膜上腔-每次注入0.1-0.3毫升;效果:由于诱发器官型性器官而导致视神经结构和功能恢复,从而减少了失明和视力障碍组织再生,包括视神经血管网,其椎间盘和pa周围脉络膜。; 2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号